Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge

Neuroscience Letters

Volumn 412, Issue 2, 2007, Pages 168-172

  Birgner, Carolina ^a   Kindlundh Högberg, Anna M S ^a   Nyberg, Fred ^a   Bergström, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anabolic androgenic steroids; Dopamine; Microdialysis; Nandrolone decanoate; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; DECA DURABOL; DOPAMINE; HOMOVANILLIC ACID; NANDROLONE DECANOATE; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG DEPENDENCE; ELECTROCHEMICAL DETECTION; EXTRACELLULAR FLUID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMPLANT; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROVOCATION TEST; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; ANABOLIC AGENTS; ANIMALS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOWN-REGULATION; DRUG INTERACTIONS; EXTRACELLULAR FLUID; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; NANDROLONE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 33846037204     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.11.001     Document Type: Article

References (35)

1. Ballard C.L., and Wood R.I. Intracerebroventricular self-administration of commonly abused anabolic-androgenic steroids in male hamsters (Mesocricetus auratus): nandrolone, drostanolone, oxymetholone, and stanozolol. Behav. Neurosci. 119 (2005) 752-758
2. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
3. Birgner C., Kindlungh-Högberg A.M.S., Ploj K., Lindblom J., Nyberg F., and Bergström L. Effects on rat brain dopamine and DOPAC levels after sub-chronic nandrolone administration followed by an amphetamine challenge. Pharmacologyonline (2006)
4. Bitran D., Hilvers R.J., Frye C.A., and Erskine M.S. Chronic anabolic-androgenic steroid treatment affects brain GABA(A) receptor-gated chloride ion transport. Life Sci. 58 (1996) 573-583
5. Celerier E., Ahdepil T., Wikander H., Berrendero F., Nyberg F., and Maldonado R. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence. Neuropharmacology 50 (2006) 788-806
6. Celerier E., Yazdi M.T., Castane A., Ghozland S., Nyberg F., and Maldonado R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur. J. Pharmacol. 465 (2003) 69-81
7. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375 (1999) 13-30
8. Frye C.A., Rhodes M.E., Rosellini R., and Svare B. The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites. Pharmacol. Biochem. Behav. 74 (2002) 119-127
9. Fudala P.J., Weinrieb R.M., Calarco J.S., Kampman K.M., and Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann. Clin. Psychiatry 15 (2003) 121-130
10. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
11. Grimes J.M., Ricci L.A., and Melloni Jr. R.H. Glutamic acid decarboxylase (GAD65) immunoreactivity in brains of aggressive, adolescent anabolic steroid-treated hamsters. Horm. Behav. 44 (2003) 271-280
12. Hallberg M., Johansson P., Kindlundh A.M., and Nyberg F. Anabolic-androgenic steroids affect the content of substance P and substance P(1-7) in the rat brain. Peptides 21 (2000) 845-852
13. Johansson P., Hallberg M., Kindlundh A., and Nyberg F. The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res. Bull. 51 (2000) 413-418
14. Johansson P., Lindqvist A., Nyberg F., and Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol. Biochem. Behav. 67 (2000) 271-279
15. Johansson P., Ray A., Zhou Q., Huang W., Karlsson K., and Nyberg F. Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci. Res. 27 (1997) 185-189
16. Kanayama G., Cohane G.H., Weiss R.D., and Pope H.G. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?. J. Clin. Psychiatry 64 (2003) 156-160
17. Kindlundh A.M., Isacson D.G., Berglund L., and Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 94 (1999) 543-553
18. Kindlundh A.M., Lindblom J., Bergstrom L., Wikberg J.E., and Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur. J. Neurosci. 13 (2001) 291-296
19. Kindlundh A.M., Lindblom J., and Nyberg F. Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain. Brain Res. 979 (2003) 37-42
20. Kindlundh A.M., Rahman S., Lindblom J., and Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci. Lett. 356 (2004) 131-134
21. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
22. Kurling S., Kankaanpaa A., Ellermaa S., Karila T., and Seppala T. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats. Brain Res. 1044 (2005) 67-75
23. Le Greves P., Huang W., Johansson P., Thornwall M., Zhou Q., and Nyberg F. Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neurosci. Lett. 226 (1997) 61-64
24. Lindblom J., Kindlundh A.M., Nyberg F., Bergstrom L., and Wikberg J.E. Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels. Brain Res. 986 (2003) 139-147
25. Lindholm S., Rosin A., Dahlin I., Georgieva J., and Franck J. Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus accumbens. Brain Res. 915 (2001) 176-184
26. Lindqvist A.S., Johansson-Steensland P., Nyberg F., and Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behav. Brain Res. 133 (2002) 21-29
27. Lukas S.E. CNS effects and abuse liability of anabolic-androgenic steroids. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 333-357
28. Magnusson K., Hallberg M., Hogberg A.M., and Nyberg F. Administration of the anabolic androgenic steroid nandrolone decanoate affects substance P endopeptidase-like activity in the rat brain. Peptides 27 (2006) 114-121
29. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
30. Nilsson S., Baigi A., Marklund B., and Fridlund B. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur. J. Public Health 11 (2001) 195-197
31. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. (1996), Academic Press, Inc., 525 B Street, Suit 1900, San Diego, California 92101-4495, USA
32. Schroeder J.P., and Packard M.G. Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats. Neurosci. Lett. 282 (2000) 17-20
33. Thiblin I., Finn A., Ross S.B., and Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br. J. Pharmacol. 126 (1999) 1301-1306
34. Thiblin I., Lindquist O., and Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J. Forensic Sci. 45 (2000) 16-23
35. Yesalis C.E., and Bahrke M.S. Anabolic-androgenic steroids. Sports Med. 19 (1995) 326-340 (current issues)